Follow-up of women with breast cancer: comparison between MRI and FDG PET. (Q53648542)

16 May 2018

title

Follow-up of women with breast cancer: comparison between MRI and FDG PET. (English)

1 reference

16 May 2018

Fluorodeoxyglucose Positron Emission Tomography

main subject

1 reference

6

1 reference

16 May 2018

Rahel Kubik

8

1 reference

16 May 2018

author name string

Gerhard W Goerres

1

1 reference

16 May 2018

Sven C A Michel

2

1 reference

16 May 2018

Mathias K Fehr

3

1 reference

16 May 2018

Achim H Kaim

4

1 reference

16 May 2018

Hans C Steinert

5

1 reference

16 May 2018

Gustav K von Schulthess

7

1 reference

16 May 2018

language of work or name

English

0 references

publication date

13 November 2002

1 reference

16 May 2018

published in

European Radiology

1 reference

16 May 2018

volume

13

1 reference

16 May 2018

issue

7

1 reference

16 May 2018

page(s)

1635-1644

1 reference

16 May 2018

Comparison of pharmacokinetic MRI and [18F] fluorodeoxyglucose PET in the diagnosis of breast cancer: initial experience

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00330-002-1720-8

MR imaging of the breast for the detection, diagnosis, and staging of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-002-1720-8

MRI of the breast: state of the art.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-002-1720-8

An automatic classification technique for attenuation correction in positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-002-1720-8

Accelerated image reconstruction using ordered subsets of projection data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-002-1720-8

Breast carcinoma: effect of preoperative contrast-enhanced MR imaging on the therapeutic approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-002-1720-8

Use of positron emission tomography in evaluation of brachial plexopathy in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-002-1720-8

Evaluation of breast masses and axillary lymph nodes with [F-18] 2-deoxy-2-fluoro-D-glucose PET

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-002-1720-8

Comparison of magnetic resonance imaging and conventional triple assessment in locally recurrent breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-002-1720-8

Value of MR Mammography in the Detection and Exclusion of Recurrent Breast Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-002-1720-8

Assessment of breast cancer recurrence with contrast-enhanced subtraction MR imaging: preliminary results in 26 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-002-1720-8

Tumor recurrence versus fibrosis in the irradiated breast: differentiation with dynamic gadolinium-enhanced MR imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-002-1720-8

Value of combined FDG PET and MR imaging in the evaluation of suspected recurrent local-regional breast cancer: preliminary experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-002-1720-8

Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography and technetium-99m methoxyisobutylisonitrile scintimammography in the detection of breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-002-1720-8

Contrast-enhanced MRI of the breast after limited surgery and radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-002-1720-8

FDG PET in head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-002-1720-8

American Society of Clinical Oncology guideline on the role of bisphosphonates in breast cancer. American Society of Clinical Oncology Bisphosphonates Expert Panel

21 January 2018

1 reference

12 December 2020

Overview of the current status of PET in breast cancer imaging

1 reference

12 December 2020

Magnetic resonance imaging in the diagnosis of local recurrences in breast cancer

1 reference

12 December 2020

The applications of PET in clinical oncology

1 reference

12 December 2020

18fluorodeoxyglucose positron emission tomography to detect mediastinal or internal mammary metastases in breast cancer

1 reference

12 December 2020

Value of 18fluoro-deoxyglucose positron emission tomography in the staging of recurrent breast carcinoma

1 reference

12 December 2020

Accuracy of whole-body fluorine-18-FDG PET for the detection of recurrent or metastatic breast carcinoma.

1 reference

12 December 2020

Detection of bone metastases in breast cancer by 18FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions

1 reference

12 December 2020

10.1007/S00330-002-1720-8

Identifiers

DOI

1 reference

16 May 2018

1 reference

16 May 2018